Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 267

Similar articles for PubMed (Select 15352131)

2.

Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.

Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C.

J Neurosci. 2006 Jun 14;26(24):6583-8. Erratum in: J Neurosci. 2006 Jul 5;26(27):table of contents.

3.

Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.

Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C.

Arch Gen Psychiatry. 2006 Dec;63(12):1386-95.

PMID:
17146013
4.

Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.

Hirvonen J, Karlsson H, Kajander J, Markkula J, Rasi-Hakala H, Någren K, Salminen JK, Hietala J.

Psychopharmacology (Berl). 2008 May;197(4):581-90. doi: 10.1007/s00213-008-1088-9. Epub 2008 Feb 5.

PMID:
18251011
5.

Smoking-induced ventral striatum dopamine release.

Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA.

Am J Psychiatry. 2004 Jul;161(7):1211-8.

PMID:
15229053
6.

Increased binding potential of [(11)C]raclopride during unilateral continuous microinjection of nicotine in rat striatum observed by positron emission tomography.

Tajima T, Hatano K, Suzuki M, Ogawa M, Sakiyama Y, Kato T, Endo H, Miura H, Matsubara M, Ito K.

Synapse. 2007 Dec;61(12):943-50.

PMID:
17787002
7.

Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.

Graff-Guerrero A, Willeit M, Ginovart N, Mamo D, Mizrahi R, Rusjan P, Vitcu I, Seeman P, Wilson AA, Kapur S.

Hum Brain Mapp. 2008 Apr;29(4):400-10.

PMID:
17497628
8.

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

Vollenweider FX, Vontobel P, Oye I, Hell D, Leenders KL.

J Psychiatr Res. 2000 Jan-Feb;34(1):35-43.

PMID:
10696831
9.

Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.

Ginovart N, Galineau L, Willeit M, Mizrahi R, Bloomfield PM, Seeman P, Houle S, Kapur S, Wilson AA.

J Neurochem. 2006 May;97(4):1089-103. Epub 2006 Apr 5.

PMID:
16606355
10.

Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.

Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, Cooper T, Kegeles L, Zarahn E, Abi-Dargham A, Haber SN, Laruelle M.

J Cereb Blood Flow Metab. 2003 Mar;23(3):285-300.

PMID:
12621304
11.
12.

Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study.

Ouchi Y, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Sakamoto M.

J Cereb Blood Flow Metab. 2002 Jun;22(6):746-52.

13.

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.

Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ.

Brain. 2009 May;132(Pt 5):1366-75. doi: 10.1093/brain/awn337. Epub 2009 Jan 19.

15.

Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.

Brody AL, Mandelkern MA, Olmstead RE, Allen-Martinez Z, Scheibal D, Abrams AL, Costello MR, Farahi J, Saxena S, Monterosso J, London ED.

Neuropsychopharmacology. 2009 Jan;34(2):282-9. doi: 10.1038/npp.2008.87. Epub 2008 Jun 18.

16.

Cue-induced dopamine release predicts cocaine preference: positron emission tomography studies in freely moving rodents.

Schiffer WK, Liebling CN, Reiszel C, Hooker JM, Brodie JD, Dewey SL.

J Neurosci. 2009 May 13;29(19):6176-85. doi: 10.1523/JNEUROSCI.5221-08.2009.

17.

A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.

Narendran R, Mason NS, Laymon CM, Lopresti BJ, Velasquez ND, May MA, Kendro S, Martinez D, Mathis CA, Frankle WG.

J Pharmacol Exp Ther. 2010 May;333(2):533-9. doi: 10.1124/jpet.109.163501. Epub 2010 Jan 26.

18.

Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.

Talvik M, Nordström AL, Okubo Y, Olsson H, Borg J, Halldin C, Farde L.

Psychiatry Res. 2006 Dec 1;148(2-3):165-73. Epub 2006 Nov 13.

PMID:
17095199
19.

Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers.

Dagher A, Bleicher C, Aston JA, Gunn RN, Clarke PB, Cumming P.

Synapse. 2001 Oct;42(1):48-53.

PMID:
11668590
20.

Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine.

Boileau I, Dagher A, Leyton M, Welfeld K, Booij L, Diksic M, Benkelfat C.

J Neurosci. 2007 Apr 11;27(15):3998-4003.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk